ArticleScientific reports2026

Retrospective analysis of clinical outcomes and risk factors in hematopoietic cell transplantation for relapsed or refractory mantle cell lymphoma in the post-ibrutinib era.

Satoshi Yamasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.